PUBLISHED DATE : Jun 2020 | Pages : 293
| Up to $1000 off | Untill Oct 2020 |
Fill out your details & get your free sample
Infusion Pumps Market Size, Share, Trends Analysis Report by Product (Large-volume Infusion Pumps, Syringe, Insulin, Enteral Feeding Pumps, Elastomeric, and Implantable), Technology (Traditional and Specialty), Usage (Stationary and Ambulatory), Application (Oncology, Diabetics, Gastroenterology, Pediatrics & Neonatology, Pain Management, and Others), End-users (Hospitals, Home Care Settings, Nursing Homes, and Others), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
293 Pages
65 Tables
163 Charts
5 Regions
18 Countries
45 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 11 Billion (2025) |
| CAGR | 8% (2020-2025) |
| HISTORICAL YEAR | 2018-2019 |
| BASE YEAR | 2019 |
| FORECAST PERIOD | 2020–2025 |
| MARKET SEGMENTATION | Product (Large-volume Infusion Pumps, Syringe, Insulin, Enteral Feeding Pumps, Elastomeric, and Implantable), Technology (Traditional and Specialty), Usage (Stationary and Ambulatory), Application (Oncology, Diabetics, Gastroenterology, Pediatrics & Neonatology, Pain Management, and Others), End-users (Hospitals, Home Care Settings, Nursing Homes, and Others) |
| GEOGRAPHICAL ANALYSIS | Europe, North America, Latin America, Middle East & Africa, and APAC |
| COUNTRIES COVERED | US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and Turkey |
The infusion pumps market size to reach USD 11 billion by 2025, growing at a CAGR of 8% during the forecast period. The global infusion pumps market is one of the fastest-growing segments in the medical device market. The market is growing at a significant rate, which can be attributed to the prevalence of lifestyle-related diseases such as diabetics, increased surgery volumes, the anesthetic usage in pain management, pediatric neonate nutritional supply, and the rise in cancer patients. The demand for infusion pumps has increased phenomenally due to the outbreak of COVID-19. With the increase in the number of infections across the world, hospitals are facing a shortage of infusion pumps to treat COVID-19 patients using nebulization support. Therefore, governments are ordering thousands of infusion pumps from manufacturers. With the sudden surge in demand for infusion pumps, both global and domestic players are ramping up their production capabilities to meet the rising demand, thereby increasing growth prospects.
This research report includes a detailed segmentation by
In 2019, the volumetric infusion segment accounted for a share of 28%. They are used to provide safe and accurate delivery of intravenous fluid products to patients. The transfusion of a large number of body fluids and electrolytes can only be administered by volumetric infusion pumps; therefore, they are witnessing high application, especially in small and medium-sized hospitals.
A wide range of applications in healthcare and non-healthcare segment drives the demand for syringe pumps. The main advantage is the high precision when dispensing small volumes and more flexible dispensing capacity, easier and smaller pulsations. The number of syringe pumps used in general cardiovascular and anesthesia departments is higher than other models, hence their contribution is high.
Approximately 463 million adults across the world are living with diabetes in 2019, and this count is expected to reach 700 million by 2045. Among 79% of adults with diabetes are in low and middle-income countries. With the increasing awareness of insulin pump therapy, patients are shifting toward insulin pumps over conventional diabetes management treatment options. The usage is witnessed higher among younger diabetes patients than elderly people that are more inclined toward self-injection practices.
The specialty segment dominated the global infusion pumps market and accounted for the largest market shares of 41%. Insulin pumps, enteral feeding, and implantable infusion pumps are considered specialty infusion pumps. The dominant share of this segment can be attributed to the increasing prevalence and incidence of non-communicable diseases such as diabetes, increase surgery volume, which demands the infusion transfer of medicine, the increase in people suffering from liver cancers, the usage of enteral pumps in neonates born with multiple complications. All these factors are contributing to higher demand in the market.
Traditional pumps include a syringe, volumetric, and PCA. They are used in medical settings such as mobile, home, and long-term care settings. They are usable in both stationary and mobile environments to administer pain medication, antibiotics, chemotherapy medication, and hydrating fluids. Compared to specialty pumps, the medication error is higher in the traditional ones. This is one of the factors, which is limiting the adoption in the market. Although they are widely used in hospital settings, limited scope for innovations, and a slow reduction in the target population are expected to decline their market share during the forecast period.
The demand for stationary pumps is increasing as they are widely applied in clinical emergency care settings in hospitals. Large volumes are widely used for saline solutions, antibiotics, nutrition transfer to the patient, and small volume are used for hormones, insulin, and powerful narcotic administration in small doses to patients. The growing number of home patients receiving medical care for chronic conditions has increased, hence the usage of stationary equipment in homecare settings fuel the demand for infusion pumps.
The rise in several types of cancers across the globe is one of the primary reasons for the growth of malnutrition cases, which, in turn, are propelling the usage of enteral feeding devices and syringe pumps to administer medications to patients. The high prevalence of the diabetic population in developed and developing regions is majorly contributing to the surge of insulin pumps across the globe.
Healthcare professionals in hospitals use infusion pumps to deliver medications in the patient’s body in a controlled manner. The increase in the number of patients admitted to ICUs and the rise in chronic diseases are the major factors increasing the market share of the hospital segment. The availability of skilled healthcare professionals with high knowledge and expertise in the infusion pump technology has attracted patients to hospitals than other healthcare providers, thereby the segment growth.
The home healthcare setting segment is growing at a faster rate and is likely to capture infusion pumps market share in the future with the increased adoption of home healthcare services in developed countries. The slow shift of healthcare facilities from hospitals to home care settings is the major factor for the growth of the segment. Home healthcare nurses are greatly affecting the management of adverse effects of chemotherapy at home, increasing the quality of life, and improving patient outcomes.
North America is leading the global infusion pumps market. The US and Canada accounted for a share of 92% and 8%, respectively, in North America in 2019. In the US, a high percentage of people suffering from liver cancers have been reinforcing the demand for infusion pumps.
The region is witnessing a steady growth of infusion pumps due to the growing geriatric population and the increasing prevalence of several lifestyle-related diseases. However, one of the important reasons for the dominance of North America in the global market is infusion pumps are covered by insurance companies. This factor is positively affecting market growth.
The global infusion pumps market share is fragmented by the presence of several global, regional, and domestic vendors. B. Braun Melsungen, Baxter, BD, Fresenius Kabi, ICU Medical, Medtronic, and Smiths Medical are leading vendors. Most key vendors are focused on developing and commercializing infusion pumps catering to several requirements of end-users. They have also increased their R&D investment to develop new products and streamline and improve error-free equipment. Hence, the market is witnessing the development of highly advanced and innovative infusion pumps, especially insulin pumps.
Segmentation by Product
By Technology
By Usage
By Application
By End-users
By Geography
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
Fill out your details & get your free sample
DAYS
HOURS
MINUTES
SECONDS
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
Want to know more about the report or any specific requirement?
Click to Email +1-312-235-2040
